niacin and tamoxifen
niacin has been researched along with tamoxifen in 20 studies
Research
Studies (20)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Dalessandri, KM | 1 |
| Perumal, SS; Sachdanandam, P; Shanthi, P | 1 |
| Sachdanandam, P; Shanthi, P; Sundravel, S | 1 |
| Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Vijayasarathy, K; Yuvaraj, S | 4 |
| Premkumar, VG; Sachdanandam, P; Shanthi, P; Yuvaraj, S | 1 |
| Gangadaran, SG; Premkumar, VG; Sachdanandam, P; Shanthi, P; Vijayasarathy, K; Yuvaraj, S | 1 |
| Georgakopoulos, CD; Georgalas, I; Makri, OE | 1 |
| Anderson-Nelson, S; Lamba, N | 1 |
Reviews
3 review(s) available for niacin and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced macular edema.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Fingolimod Hydrochloride; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Interferons; Macular Edema; Niacin; Ophthalmic Solutions; Propylene Glycols; Sphingosine; Tamoxifen; Taxoids; Thiazolidinediones; Timolol | 2013 |
Medication induced retinal side effects.
Topics: Antimalarials; Canthaxanthin; Deferoxamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Interferons; Male; Niacin; Ophthalmoscopy; Phenothiazines; Phosphodiesterase 5 Inhibitors; Retinal Diseases; Risk Assessment; Severity of Illness Index; Tamoxifen | 2014 |
Trials
3 trial(s) available for niacin and tamoxifen
| Article | Year |
|---|---|
Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoembryonic Antigen; Coenzymes; Dietary Supplements; Female; Humans; Middle Aged; Mucin-1; Niacin; Prognosis; Riboflavin; Tamoxifen; Ubiquinone; Vitamin B Complex | 2007 |
Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Coenzymes; Cytokines; Drug Therapy, Combination; Female; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Middle Aged; Niacin; Prognosis; Riboflavin; Tamoxifen; Tumor Necrosis Factor-alpha; Ubiquinone; Vascular Endothelial Growth Factor A; Vitamins | 2007 |
Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dietary Supplements; DNA Methylation; DNA Repair Enzymes; DNA, Neoplasm; Female; Humans; Middle Aged; Niacin; Poly(ADP-ribose) Polymerases; Riboflavin; Single-Blind Method; Tamoxifen; Ubiquinone | 2008 |
Other Studies
14 other study(ies) available for niacin and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Multiple Methods for Reduction of Lipoprotein(a).
Topics: Ascorbic Acid; Carnitine; Coronary Artery Disease; Diet, Reducing; Estrogens; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Mutation; Niacin; Receptors, LDL; Risk Factors; Tamoxifen | 2002 |
Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antioxidants; Body Weight; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coenzymes; Drug Combinations; Female; Lipid Peroxidation; Mitochondria; Niacin; Rats; Rats, Sprague-Dawley; Riboflavin; Tamoxifen; Ubiquinone | 2005 |
Therapeutic potential of riboflavin, niacin and ascorbic acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbohydrate Metabolism; Carcinoma; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Neoplasm Metastasis; Niacin; Rats; Rats, Sprague-Dawley; Riboflavin; Tamoxifen | 2006 |
Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Topics: Adult; Aged; Breast Neoplasms; Cholesterol, LDL; Cholesterol, VLDL; Coenzymes; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Middle Aged; Niacin; Postmenopause; Riboflavin; Tamoxifen; Triglycerides; Ubiquinone | 2007 |
Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antioxidants; Breast Neoplasms; Enzymes; Female; Humans; Lipid Peroxidation; Lipids; Middle Aged; Niacin; Oxidative Stress; Riboflavin; Tamoxifen; Thiobarbituric Acid Reactive Substances; Ubiquinone | 2008 |
Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Blood Chemical Analysis; Breast Neoplasms; Dietary Supplements; Electron Transport Chain Complex Proteins; Female; Humans; Lipids; Middle Aged; Niacin; Postmenopause; Riboflavin; Tamoxifen; Ubiquinone; Vitamin B Complex | 2009 |